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Abstract 
Background: Congenital diaphragmatic hernia (CDH) is a rare congenital anomaly and remains among the most 
challenging ICU-managed disease. Beside severe pulmonary hypertension, lung hypoplasia and major abdominal 
surgery, infective complications remain major determinants of outcome. However, the specific incidence of sepsis as 
well as associated risk factors is unknown.
Methods: This prospective, 4-year observational study took place in the pediatric intensive care and neonatal medi-
cine department of the Paris South University Hospitals (Le Kremlin-Bicêtre, France), CDH national referral center and 
involved 62 neonates with CDH.
Main results: During their ICU stay, 28 patients (45%) developed 38 sepsis episodes. Ventilator-associated pneumo-
nia (VAP: 23/38; 31.9 VAP per 1000 days of mechanical ventilation) and central line-associated blood stream infections 
(CLABSI: 5/38; 5.5 per 1000 line days) were the most frequently encountered infections. Multivariate analysis showed 
that gestational age at birth and intra-thoracic position of liver were significantly associated with the occurrence of 
sepsis. Infected patients had longer duration of mechanical and noninvasive ventilation (16.2 and 5.8 days, respec-
tively), longer delay to first feeding (1.2 days) and a longer length of stay in ICU (23 days), but there was no difference 
in mortality.
Conclusions: Healthcare-associated infections, and more specifically VAP, are the main infective threat in children 
with CDH. Sepsis has a significant impact on the duration of ventilator support and ICU length of stay but does not 
impact mortality. Low gestational age and intra-thoracic localization of the liver are two independent risk factors 
associated with sepsis.
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Background
Congenital diaphragmatic hernia (CDH) is a rare con-
genital anomaly of the diaphragm with an incidence 
of approximately 1–3.5 per 10,000 births [1–3]. CDH 
patients suffer from severe respiratory failure caused by 
a combination of defect in the muscular or tendinous 
portion of the diaphragm, pulmonary hypoplasia and 
persistent pulmonary hypertension (PAH) [4]. Once the 
diaphragm is surgically repaired, lung morbidities are 
considered to be the main determinant for postnatal out-
come, resulting in an overall survival rate up to 84% [5]. 
With the improvement in neonatal care of children with 
CDH, other factors than pulmonary hypoplasia and PAH 
impact on the prognosis like nutrition and infections 
[6, 7]. It is recognized that following the initial neonatal 
period, recurrent respiratory infections are frequently 
reported complications and are responsible for most hos-
pital readmissions [7]. However, there are very few data 
concerning sepsis and healthcare-associated infection 
(HCAI) in this population and its impact on prognosis.
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The aim of this study is to evaluate the incidence of 
sepsis and HCAI in children with CDH and to identify 
the associated risk factors.
Methods
We performed prospective, monocentric study that 
included all consecutive neonates born with a CDH 
who were between December 2009 and January 2015 in 
the neonatal intensive care unit of the Paris South Uni-
versity Hospitals in Kremlin-Bicêtre, France. Our center 
is a national referral center for CDH management. Dur-
ing the study period, 161 pregnant mothers with prena-
tally diagnosed CDH were referred from other centers 
for antenatal evaluation for potential inclusion in fetal 
tracheal occlusion (FETO) trials (AB; TOTAL Trial 1 
NCT007637737; TOTAL Trial 2 NCT01240057). Subse-
quently, 82 (51%) with the most severe CDH form were 
selected and oriented to our center for perinatal man-
agement. These patients were identified from a prospec-
tively maintained database of all newborn admitted in 
our unit with congenital diaphragmatic hernia. In addi-
tion, patients with sepsis were identified in a prospective 
HCAI and sepsis surveillance program and matched with 
the institutional program of medicalization of informa-
tion systems (PMIS) database using the 10th version of 
the International Classification of Diseases. All newborns 
dying within the first 3 days of life were excluded. Addi-
tional data missing in the prospective database were ret-
rospectively collected from patient’s files. All patients’ 
data were secondarily anonymized. Children representa-
tives were informed. The study was reviewed by the 
Ethic Committee of the French Society of Intensive Care 
(Société de Reanimation de Langue Française), which 
waived the need of parents signed informed consent (CE 
SRLF-15-38).
The primary endpoint was to describe the incidence 
of sepsis in children with CDH. Secondary endpoints 
were the identification of associated risk factors and to 
evaluate the impact on patients’ outcome. The follow-
ing data were collected for all patients: sex, gestational 
age at birth, gestational age at diagnosis, birth weight, 
hernia type (right or left), best observed/expected lung–
head ratio (O/E LHR), intra-thoracic position of liver, the 
period of diagnosis (ante versus postnatal), fetal tracheal 
occlusion (FETO) during pregnancy, antenatal steroid 
therapy, delay between delivery and surgery, presence 
of surgical abdominal plate or chest tube, use of various 
catheters (umbilical venous and artery catheters, periph-
eral arterial catheter, centrally inserted central venous 
catheter (CVC) and peripherally inserted central cath-
eter (PICC). Sepsis was defined as clinical symptoms of 
infection and/or sudden clinical deterioration together 
with significant increase in C-reactive protein (CRP) and/
or procalcitonin (PCT). Healthcare-associated infections 
were defined according to the 2016 update of Center for 
Disease Control HCAI criteria (Additional file  1: Table 
S1) [8, 9].
Data on infection were also collected: type of infection, 
presence of septic shock, identification of bacteria, tem-
perature, CRP, PCT, leukocyte and neutrophil counts, 
initial antibiotic therapy and duration, time to first nega-
tive PCT. The outcome data were durations of mechani-
cal ventilation, duration of high-frequency oscillatory 
ventilation (HFOV), duration of noninvasive ventilation, 
time to first day of feeding, weight at day five, presence 
of PAH, use of pulmonary vasodilators, use of inotrope 
treatments, length of hospitalization stay and death.
The results of the descriptive analysis were expressed as 
numbers and percentages for qualitative variables and as 
mean and standard deviation for quantitative variables. 
Two-tailed Fisher’s exact test for quantitative variables 
and Chi-square test for qualitative variable were used. 
Risk of infection was modeled using a multivariate logis-
tical regression analysis. A stepwise selection was used, 
and the final model was adjusted on all variables associ-
ated with a p value below 0.2.
Results
Patients characteristics
Eighty-two children were hospitalized during the study 
period. Sixteen children died within the first 3 days of life 
(38% of right CDH, no sepsis), and two additional patients 
were excluded because the diagnosis was made after the 
neonatal period (2.4 and 6  months after birth). The 62 
remaining newborns (all inborn) were included in the 
study. Patients’ characteristics are described in Table  1. 
The mean gestational age at birth was 38.4 ± 2.2 weeks 
and the mean birth weight was 3072  ±  671  g. Ten 
patients (16%) were preterm. Most patients had left-
sided CDH (90%, n = 56) and 38.7% of the patients had 
an intra-thoracic ascension of liver (n = 24). 83.9% of the 
patients (n = 52) were diagnosed during pregnancy, the 
mean age of CDH diagnosis was 27.6 ±  7.4  weeks and 
the mean of O/E LHR was 42.1%. Seven patients (11.3%) 
underwent a FETO procedure during pregnancy and 
nine (14.5%) had antenatal steroids. The mean length of 
hospitalization was 21.9 ± 27.8 days.
Description of sepsis episodes
Twenty-eight patients (45%) developed 38 sepsis epi-
sodes during the hospitalization period. Four patients 
developed two different sepsis episodes, one patient 
developed three and one patient developed five episodes 
during the hospitalization. Clinical and laboratory find-
ings are presented in Table 2. VAP was the main cause of 
sepsis and accounted for 60.5% of all cases (23/38) with 
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an incidence density of 31.9 per 1000  days of mechanic 
ventilation. VAP was followed by CLABSI (5/38, 5.5 per 
1000 line days, 13.2% of the infections) and by urinary 
tract infections and bacteremia with no source identi-
fied. Forty-seven centrally inserted CVC were used in 43 
patients including 31 left subclavian vein, 15 internal jug-
ular veins and one femoral vein CVC. CLABSI occurred 
in 3/47 (6.4%) centrally inserted CVC and in 2/19 (10.5%) 
PICC. Sepsis occurred after a mean of 22.4 ± 33.1 days 
of hospitalization. The mean time to develop VAP was 
25.5 ± 36.1 days, and CLABSI was 35.6 ± 41.9 days. Most 
patients (65.8%) had fever, while 15.8% had hypothermia 
at diagnosis. Mean CRP value was 103.2  ±  73.5  mg/L, 
and mean PCT value was 10.5 ± 21.2 μg/L. The main bac-
teria identified were Escherichia coli (22%), Staphylococ-
cus epidermidis (19.5%), Staphylococcus aureus (14.6%) 
and Enterobacter cloacae (9.8%). Vancomycin, piperacil-
lin–tazobactam, cefotaxime, gentamicin and amikacin 
were the main antibiotics used following unit protocoled 
antibiotic therapy. Antibiotics were adapted to the bac-
teria and its resistance profile in all cases. Bacteria were 
identified in 89% of all sepsis. The mean time to normal 
PCT was 6.5 ± 3.4 days, and the mean duration of antibi-
otic therapy was 8.02 ± 2.41 days.
Risk factors for infection
Using univariate comparison (Table 1), infected patients 
had a significant lower gestational age at diagnosis, lower 
observed/expected LHR than non-infected patients (O/E 
LHR range 12.5–65 vs. 27.1–69, respectively) and more 
use of antenatal steroids. Intra-thoracic liver, use of sur-
gical plate and CVC were also more frequent in infected 
patients. The difference between the two groups regard-
ing gender, gestational age at birth, proportion of pre-
term, birth weight, type of hernia, FETO, delay between 
delivery and surgery, requirement of a chest tube, umbili-
cal venous and arterial catheters, peripheral arterial cath-
eter and PICCs was not significant. After multivariate 
logistical regression analysis and a stepwise selection of 
variables (Table 3), the gestational age at birth (in weeks), 
the birth weight (in grams), an intra-thoracic position of 
liver and the presence of a centrally inserted CVC were 
Table 1 Patients characteristics
Values are expressed as number (%), or mean ± SD
*X X number of missing data; LHR lung-to-head ratio; FETO fetal tracheal occlusion
* Univariate analysis
No sepsis (n = 34) Sepsis (n = 28) p value*
Gender (male) 26 (76.5%) 19 (67.9%) 0.57
Gestational age at birth (weeks) 38.8 (2.1) 37.8 (2.2) 0.09
Term of birth
 Preterm (<37 weeks) 4 (11.8%) 6 (21.4%) 0.49
 Term (≥37 weeks) 30 (88.2%) 22 (78.6%) 0.79
  ≥37 and <39 weeks 8 11
  ≥39 and <42 weeks 22 11
Birth weight (g) 3092 (633) 3048 (726)
Gestational age at diagnosis (weeks) 30.0 (7.5) 25.1 (6.3) <0.01
Type
 Left 31 (91.2%) 25 (89.3%) 0.80
 Right 3 (8.8%) 3 (10.7%)
Best observed/expected LHR (%) 47.2 ± 12.2 37.8 ± 12.5 0.02
Intra-thoracic liver 7 (21.2%)*1 17 (60%) <0.01
Antenatal diagnosis 26 (76.5%) 26 (92.8%) 0.08
FETO 3 (8.8%) 4 (14.3%) 0.49
Antenatal steroids 1 (2.9%) 8 (28.6%) <0.01
Time before surgery (days) 2.26 (1.9) 2.14 (1.0) 0.74
Patch repair 4 (12.5%)*2 13 (46.4%) <0.01
Chest tube 7 (25.9%)*2 4 (12.5%)*1 0.18
Umbilical venous catheter 29 (85.3%) 26 (92.9%) 0.34
Umbilical arterial catheter 4 (11.8%) 3 (10.7%) 0.89
Arterial catheter 2 (5.8%) 5 (17.9%) 0.13
Central venous catheter 17 (50.0%) 26 (92.9%) <0.01
Peripherally inserted central venous catheter 9 (26.5%) 10 (35.7%) 0.43
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significantly associated with the occurrence of an infec-
tion. With every additional week of gestation at birth, 
the OR of contracting an infection was 0.439 (95% CI 
0.224–0.862). Although most children with sepsis had a 
centrally inserted CVC (26/28), outlining the severity of 
those patients, very few developed a CLABSI.
Impact of sepsis on patients’ outcome
Infected patients had significantly poorer prognosis 
than non-infected patients (Table  4). Infected patients 
had longer duration of mechanical ventilation, longer 
duration of noninvasive ventilation, longer delay to first 
feeding and longer duration of hospitalization. Infected 
patients also requested significantly more inotrope treat-
ment, fluid resuscitation and red blood cells transfusion 
(data not shown). There was no significant difference in 
death rate in the two groups.
Discussion
The major finding of this study is that lower gestational 
age at birth is independently associated with sepsis and 
HCAI in children with CDH, representing a major risk 
factor for associated morbidities. Similarly, following 
neonatal congenital heart surgery, HCAI is known to be 
associated with prolonged length of stay in ICU as well as 
increased mortality and costs [10–14].
Although HCAI is representing the vast majority of 
sepsis (30/38), VAP is clearly emerging as the main cause 
of infection in this subset of neonatal patients. The preva-
lence of VAP in this population (31.9 per 1000 ventilator 
days) is higher than in other neonates admitted in our 
unit during the same period of time (2009–2014) with 
a mean of 16.5 per 1000 ventilator days (yearly range 
9.1–19.3 per 1000). In most studies, rate of VAP var-
ies between 0.2 and 10.9 per 1000 ventilator days, and a 
recent meta-analysis found a prevalence ranging from 
8.1 to 57.1% [9, 15–17]. Beside local prevention bun-
dles application, the mechanism by which neonates with 
CDH have higher rates of VAP is not clear. A suscepti-
bility to pulmonary infection could be explained by lung 
hypoplasia including fewer alveoli, reduced vascular bed 
Table 2 Sepsis characterization
N number, SD standard deviation, VAP ventilator-associated pneumonia
* In 28 patients
Data N (%) or mean (SD)
Number of sepsis episodes* 38
Type of sepsis
 Meningitis 1 (2.6%)
 Ventilator-associated pneumonia 23 (60.5%)
  Same side as hernia 6 (26%)
  Opposite side as hernia 11 (48%)
  Both lungs 6 (26%)
 Urinary tract infection 3 (7.9%)
  With urinary catheter 1 (2.6%)
  Without urinary catheter 2 (5.3%)
 Central line-associated bloodstream infection 5 (13.2%)
  Central venous catheter 3 (7.9%)
  Peripherally inserted central catheter 2 (5.3%)
 Bacteremia with no origin found 3 (7.9%)
 Early-onset neonatal sepsis 2 (5.3%)
 Surgical site infection 1 (2.6%)
Septic shock 7 (18.4%)
Delay between delivery and sepsis (days)
 All infections 22.4 (33.1)
 VAP 25.5 (36.1)






Gestational age at birth 
(weeks)
0.439 0.224–0.862 0.016
Birth weight (grams) 1.003 1.001–1.006 0.012
Right CDH 0.894 0.783–1.022 0.099
Intra-thoracic liver 8.319 1.439–48.104 0.018
Centrally inserted venous 
catheter
34.582 2.864–417.635 0.005
Peripherally inserted central 
catheter
3.836 0.627–23,485 0.145
Table 4 Impact of sepsis on patients’ outcomes
Values are expressed as mean (SD) or * number (percent)
OR odd ratio, HFOV high-frequency oscillatory ventilation, NO nitric oxide, PAH 
pulmonary arterial hypertension defined as tricuspid regurgitation >3 m/s 





p value or 
OR (95% CI)
Duration of mechanical 
ventilation (days)
20.5 (15.6) 4.3 (4.0) <0.0001
Duration of HFOV (days) 10.2 (9.9) 1.2 (2.4) <0.0001
Duration of noninvasive 
ventilation (days)
6.9 (12.3) 1.1 (2.4) <0.01
Time to first day  
of feeding (days)
6.0 (2.3) 4.8 (2.0) 0.049
Weight at day 5 (g) 3246 (769) 3076 (644) 0.37
Duration of  
hospitalization (days)
34.6 (35.9) 11.6 (11.6) <0.001
Volemic expansion* 21 (75.0%) 14 (41.1%) 4.2 (1.4–12.8)
Inotrope treatment* 24 (85.7%) 17 (50.0%) 5.9 (1.7–21.0)
NO treatment* 20 (71.4%) 9 (26.4%) 6.9 (2.2–21.2)
PAH* 27 (96.4%) 27 (79.4%) 7.0 (0.8–60.0)
Death* 7 (25.0%) 5 (14.7%) 1.9 (0.6–6.9)
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and a certain degree of reduced ciliary epithelium. The 
fact that the most severe cases (with liver up) were more 
prone to infection is in favor of this hypothesis. Hypo-
plastic lung immunity might not be as efficient as in nor-
mal lungs, explaining why children with CDH have an 
increased sensitivity to the development of VAP. Some 
indirect observations are supporting this hypothesis. It 
was shown that adult patients with pulmonary fibrosis 
have increased bacterial burden due to poorer lung vas-
cularization [18]. Although altered immunity has not 
been described in neonates with CDH, recently, it was 
shown that peak inspiratory pressure impacts sphin-
gomyelin degradation in CDH patients outlining the 
effects of ventilation on lung cell apoptosis and homeo-
stasis [19]. Furthermore, role of mechanical ventilation 
in potentializing the innate immune response to bacteria 
and subsequent development of VAP is now well vali-
dated [20]. In neonates with CDH and hypoplastic lung, 
mechanical ventilation is associated with a high risk of 
barotrauma potentially aggravating secondary bacterial 
insults on lung parenchyma.
In our CDH cohort, we observed a microbiological shift 
in VAP pathogen. It is usually considered that in neonatal 
VAP, the most prevalent monomicrobial pathogens are 
P. aeruginosa, K. pneumonia and S. aureus, whereas pol-
ymicrobial VAP accounted for 6–58% of the cases [9]. In 
our series, few polymicrobial infections (3/38 episodes) 
were observed, and we did not found any infection due 
to P. aeruginosa but a high proportion of other Gram-
negative bacteria, including E. coli and E. cloacae. In our 
patients, CLABSI is the second cause of sepsis. It is diffi-
cult to compare CLABSI incidence rate (5.5 par 1000 line 
days) to the neonatal literature (ranging between 1.43 
and 11 per 1000 line days), considering that most studies 
include neonates from all terms (including very low birth 
weights) and that most neonatal units are using prefer-
entially PICC and not centrally inserted CVC as routine 
practice [21–25]. Nevertheless, neonatal CLABSI inci-
dence rates are mainly caused by S. epidermidis and S. 
aureus [26]. In our series, although Gram-negative sepsis 
burden was high (55.2%), there was no CLABSI caused 
by enterobacteria.
We found that children with older gestational age at 
delivery have reduced risk of developing an infection 
in the course of hospitalization. This result leads to the 
question of the best timing of delivery of neonates with 
CDH. The CDH Study Group reported increased sur-
vival among prenatally diagnosed CDH infants born at 
early-term ages (37–38  weeks of gestation), compared 
with infants born at later term ages (39–41  weeks of 
gestation) hypothesizing an increasing severity of lung 
hypoplasia with advancing gestational age [27]. How-
ever, the results have been challenged, and other studies 
found that neonates with CDH seemed to have inferior 
neonatal and infant mortality with the increase in the 
gestational age of birth [28–31]. Although most patients 
are less than 39 and more than 37  weeks of gestational 
age, our results clearly outline the impact of lower gesta-
tional age at delivery as a major perioperative risk factor 
for infective complications. The intra-thoracic position of 
liver is also an independent risk factor for infection in our 
population. Infants with intra-thoracic liver are already 
known to have poorer neonatal outcome with greater 
death before discharge and increased risk of extracor-
poreal membrane oxygenation (ECMO) [32–35]. The 
importance of liver positioning is crucial for the outcome 
of patients, and its link to poorer long-term outcome has 
been well established [32, 36]. Among the 17 infected 
patients with liver ascension, 12 developed a VAP adding 
to the probable hypothesis of a specific lung cause to the 
development of VAP. Controlateral pneumonia, in the so-
called healthy lung, reinforces the barotrauma hypothesis 
and subsequent pathogenesis of VAP and raised the dif-
ficult question of optimal pressure/volume target ventila-
tion [20, 37, 38].
Despite its monocentric design, our cohort is char-
acterized by a highly selected case load. Interestingly, 
mortality (13/62; 21%) in our cohort is corresponding 
to those of the CDH Euro consortium (25%) as recently 
shown, outlining the adequacy of our results with larger 
European CDH centers [38]. Although one can argue 
that most infections were HCAI, and presumably pre-
ventable, our study suggest that neonates managed for 
CDH have an increased risk of developing sepsis and 
more specifically VAP compared to the general neona-
tal ICU patients. During the same period of time, in our 
unit, VAP incidence in CDH patients (23/62, 37.4%) was 
much higher than in the rest of patients ventilated for 
>12 h (68/715, 9.5%). Furthermore, the high incidence of 
VAP despite local VAP prevention bundles should raise 
the possibility that children with the most severe form of 
CDH have an intrinsic susceptibility to VAP. This has to 
be confirmed in multicenter cohort.
Conclusion
This study shows that neonates hospitalized for CDH 
have a high incidence of sepsis, mostly related to the 
development of VAP. We showed that the gestational 
age independently affects the risk of sepsis development. 
However, although the impact of sepsis on hospital mor-
bidities is strong, sepsis has no effect on mortality in 
neonates with CDH. This study urge confirmation and 
immunologic investigations aimed at studying suscepti-
bility to infections of infants with CDH and particularly 
the physiopathologic basis of VAP in hypoplastic neona-
tal lung.
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